» Articles » PMID: 10632374

Overexpression of Nm23-H2/NDP Kinase B in a Human Oral Squamous Cell Carcinoma Cell Line Results in Reduced Metastasis, Differentiated Phenotype in the Metastatic Site, and Growth Factor-independent Proliferative Activity in Culture

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2000 Jan 13
PMID 10632374
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The metastasis suppressor activity of nm23/nucleoside diphosphate (NDP) kinase was assessed using human oral squamous cell carcinoma (SCC) cell lines. When the expression of nm23/NDP kinase was compared among several SCC cell lines, nm23-H2/NDP kinase B gene product, but not nm23-HI/NDP kinase A gene product, was reduced in the metastatic cells. Transfection of nm23-H2 into the metastatic SCC cell line LMF4 caused reduction in the lung metastasis in an experimental metastasis assay. A histological analysis of the pulmonary metastatic foci revealed that although foci of the control clones were composed of anaplastic squamous cells, those of the nm23-H2-transfected clones consisted of mostly well-differentiated cells mimicking normal stratified epithelial constitution. The transfected cells were morphologically indistinguishable from the control ones in culture, but they differed from each other in that the former cells proliferated faster than the latter, became less serum dependent, and lost responsiveness to growth factors such as platelet-derived growth factor, insulin-like growth factor I, and insulin, although both clones retained sensitivity to transferrin. These results demonstrate that nm23-H2 protein does have metastasis suppressor activity for human SCC cells and suggest that this activity may be elicited by modulating growth and/or differentiation potential in response to environmental factors.

Citing Articles

Histidine Phosphorylation: Protein Kinases and Phosphatases.

Ning J, Sala M, Reina J, Kalagiri R, Hunter T, McCullough B Int J Mol Sci. 2024; 25(14).

PMID: 39063217 PMC: 11277029. DOI: 10.3390/ijms25147975.


Mechanisms of action of NME metastasis suppressors - a family affair.

Prunier C, Chavrier P, Boissan M Cancer Metastasis Rev. 2023; 42(4):1155-1167.

PMID: 37353690 PMC: 10713741. DOI: 10.1007/s10555-023-10118-x.


Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems.

Khan I, Gril B, Hoshino A, Yang H, Lee M, Difilippantonio S Clin Exp Metastasis. 2022; 39(5):815-831.

PMID: 35939247 PMC: 10642714. DOI: 10.1007/s10585-022-10182-7.


Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial-Mesenchymal State in Cancer Cells.

Huna A, Nawrocki-Raby B, Padilla-Benavides T, Gavard J, Coscoy S, Bernard D Int J Mol Sci. 2021; 22(7).

PMID: 33918324 PMC: 8038181. DOI: 10.3390/ijms22073718.


High expression of NME1 correlates with progression and poor prognosis in patients of hepatocellular carcinoma.

Yang J, Lv Z, Huang J, Zhao Y, Li Y Int J Clin Exp Pathol. 2020; 10(8):8561-8568.

PMID: 31966710 PMC: 6965413.